Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-26-000137

Executive Chair sold 26,756 shares at $76.32 ($2,041,999)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SAYER KEVIN R Executive Chair 2026-07-20 Sale 10b5-1 −26,756 $76.32 $2,041,999 328,970 D
Open-market sales · 26,756 sh · avg $76.32 · $2,041,999
Loading xslF345X06/wk-form4_1784667520.xml…